Monto Arnold S, Foster-Tucker Joshua E, Callear Amy P, Leis Aleda M, Godonou Elie-Tino, Smith Matthew, Truscon Rachel, Johnson Emileigh, Thomas Lara J, Thompson Mark S, Fry Alicia M, Flannery Brendan, Malosh Ryan E, Petrie Joshua G, Lauring Adam S, Martin Emily T
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Westat, Rockville, Maryland, USA.
J Infect Dis. 2025 Mar 17;231(3):795-804. doi: 10.1093/infdis/jiae423.
Viral respiratory illnesses are the most common acute illnesses experienced and generally follow a predicted pattern over time. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic interrupted that pattern.
The HIVE (Household Influenza Vaccine Evaluation) study was established in 2010 to follow a cohort of Southeast Michigan households over time. Initially focused on influenza, surveillance was expanded to include other major respiratory pathogens, and, starting in 2015, the population was followed year round. Symptoms of acute illness were reported, and respiratory specimens were collected and tested to identify viral infections. Based on the known population being followed, virus-specific incidence was calculated.
From 2015 to 2022, 1755 participants were followed in HIVE for 7785 person-years with 7833 illnesses documented. Before the pandemic, rhinovirus (RV) and common cold human coronaviruses (HCoVs) were the viruses most frequently identified, and incidence decreased with increasing age. Type A influenza was next but with comparable incidence by age. Parainfluenza and respiratory syncytial viruses were less frequent overall, followed by human metapneumoviruses. Incidence was highest in young children, but infections were frequently documented in all age groups. Seasonality followed patterns established decades ago. The SARS-CoV-2 pandemic disrupted these patterns, except for RV and, to a lesser extent, HCoVs. In the first 2 years of the pandemic, RV incidence far exceeded that of SARS-CoV-2.
Longitudinal cohort studies are important in comparing the incidence, seasonality, and characteristics of different respiratory viral infections. Studies documented the differential effect of the pandemic on the incidence of respiratory viruses in addition to SARS-CoV-2.
病毒性呼吸道疾病是最常见的急性疾病,通常会随着时间呈现出一种可预测的模式。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行打破了这种模式。
家庭流感疫苗评估(HIVE)研究于2010年启动,旨在长期跟踪密歇根州东南部的一组家庭。该研究最初聚焦于流感,后来监测范围扩大到包括其他主要呼吸道病原体,并从2015年开始全年跟踪该人群。研究人员记录急性疾病的症状,并收集呼吸道标本进行检测以确定病毒感染情况。根据已知的被跟踪人群,计算特定病毒的发病率。
2015年至2022年期间,HIVE研究共跟踪了1755名参与者,累计观察7785人年,记录到7833起疾病。在大流行之前,鼻病毒(RV)和普通感冒人类冠状病毒(HCoV)是最常检测到的病毒,发病率随年龄增长而下降。甲型流感次之,但各年龄组发病率相当。副流感病毒和呼吸道合胞病毒总体上出现频率较低,其次是人类偏肺病毒。幼儿的发病率最高,但所有年龄组都经常有感染记录。季节性遵循几十年前确立的模式。SARS-CoV-2大流行打破了这些模式,RV以及在较小程度上的HCoV除外。在大流行的头两年,RV的发病率远远超过SARS-CoV-2。
纵向队列研究对于比较不同呼吸道病毒感染的发病率、季节性和特征非常重要。这些研究记录了大流行对除SARS-CoV-2之外的呼吸道病毒发病率的不同影响。